TY - JOUR
KW - Adaptation, Psychological
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Buprenorphine, Naloxone Drug Combination/therapeutic use
KW - Cognitive Therapy
KW - Combined Modality Therapy
KW - Humans
KW - Methadone/therapeutic use
KW - Motivation
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/therapy
KW - Social Support
KW - United Kingdom
KW - cocaine
KW - Heroin
KW - Opioid substitution
KW - psychosocial
KW - Trial
AU - J. Marsden
AU - G. Stillwell
AU - J. Hellier
AU - A. M. Brown
AU - S. Byford
AU - M. Kelleher
AU - J. Kelly
AU - C. Murphy
AU - J. Shearer
AU - L. Mitcheson
A1 - 
AD - Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom; Lambeth Addictions, South London and Maudsley NHS Mental Health Foundation Trust, United Kingdom. Electronic address: john.marsden@kcl.ac.uk.; Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom; Lambeth Addictions, South London and Maudsley NHS Mental Health Foundation Trust, United Kingdom.; Department of Biostatistics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.; Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom; Lambeth Addictions, South London and Maudsley NHS Mental Health Foundation Trust, United Kingdom.; King's Health Economics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.; Lambeth Addictions, South London and Maudsley NHS Mental Health Foundation Trust, United Kingdom.; King's Clinical Trials Unit at King's Health Partners, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.; King's Clinical Trials Unit at King's Health Partners, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.; King's Health Economics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.; Lambeth Addictions, South London and Maudsley NHS Mental Health Foundation Trust, United Kingdom.
BT - Contemporary clinical trials
C5 - Financing & Sustainability; Opioids & Substance Use
CY - United States
JF - Contemporary clinical trials
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2017
SN - 1559-2030; 1551-7144
SP - 36
EP - 43
EP - 
T1 - Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial
T2 - Contemporary clinical trials
TI - Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial
U1 - Financing & Sustainability; Opioids & Substance Use
U2 - 27940188
VL - 53
VO - 1559-2030; 1551-7144
Y1 - 2017
Y2 - Feb
ER -